Lantheus Holdings (LNTH) Asset Writedowns and Impairment (2014 - 2026)

Lantheus Holdings' (LNTH) quarterly Asset Writedowns and Impairment came in at $1.5 million in Q1 2026, up 211.54% year-on-year from $493358.0 in Q1 2025, and up 330.43% on a QoQ basis from -$667000.0 in Q4 2025.

Lantheus Holdings (LNTH) Asset Writedowns and Impairment (2014 - 2026) Analysis & Trends

Lantheus Holdings (LNTH) has 13 years of Asset Writedowns and Impairment data on file, last reported at $1.5 million in Q1 2026.

  • On a quarterly basis, Asset Writedowns and Impairment rose 211.54% year-over-year to $1.5 million in Q1 2026; TTM through Mar 2026 was $5.1 million, a 223.75% increase from a year earlier, with the FY2025 full-year figure at $2.2 million, changed N/A from the prior year.
  • Asset Writedowns and Impairment for Q1 2026 stood at $1.5 million, up from -$667000.0 in the prior quarter.
  • Over the last five years, Asset Writedowns and Impairment for LNTH reached as high as $132.1 million in Q1 2023 and fell as low as -$1.4 million in Q1 2025.
  • Historically, Asset Writedowns and Impairment has averaged $12.4 million across 5 years, with a median of $1.7 million in 2025.
  • Across the five-year window, Asset Writedowns and Impairment soared 3680.42% in 2022 and sank 149.98% in 2025, its largest moves.
  • Year by year, Asset Writedowns and Impairment stood at $7.1 million in 2022, then slipped by 16.05% to $6.0 million in 2023, then plunged by 112.3% to -$738000.0 in 2024, then gained by 9.62% to -$667000.0 in 2025, then jumped by 330.43% to $1.5 million in 2026.
  • Per Business Quant data, the three most recent Asset Writedowns and Impairment figures were $1.5 million in Q1 2026, -$667000.0 in Q4 2025, and $1.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 88.74 Bn 86.88 Bn -
2 Teva Pharmaceutical Industries 35.87 Bn 32.13 Bn 1.97 Bn
3 Zoetis 32.28 Bn 30.34 Bn 1.62 Bn
4 Takeda Pharmaceutical 27.51 Bn 23.45 Bn 4.39 Bn
5 United Therapeutics 23.14 Bn 20.98 Bn 648.10 Mn
6 RedHill Biopharma 20.53 Bn 20.53 Bn -
7 Viatris 20.25 Bn 18.44 Bn 1.16 Bn
8 Neurocrine Biosciences 17.89 Bn 16.57 Bn 800.70 Mn
9 Elanco Animal Health 12.64 Bn 12.21 Bn 785.00 Mn
10 Lantheus Holdings 7.02 Bn 6.53 Bn 230.92 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.54 Mn
Mar 31, 2026 1.54 Mn
Dec 31, 2025 -667,000.00
Dec 31, 2025 -667,000.00
Sep 30, 2025 1.93 Mn
Sep 30, 2025 1.93 Mn
Jun 30, 2025 2.31 Mn
Jun 30, 2025 2.31 Mn
Mar 31, 2025 -1.38 Mn
Mar 31, 2025 -1.38 Mn
Dec 31, 2024 -738,000.00
Dec 31, 2024 -738,000.00
Sep 30, 2024 -1.19 Mn
Sep 30, 2024 -1.19 Mn
Jun 30, 2024 -832,000.00
Jun 30, 2024 -832,000.00
Mar 31, 2024 2.76 Mn
Mar 31, 2024 2.76 Mn
Jun 30, 2023 6.00 Mn
Jun 30, 2023 6.00 Mn